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Does NPWT improve the outcome of osteomyelitis
in HCV-HIV coinfected patient?
Ciro Pempinello, Alfredo Franco, Fiorella Martucci
CASE REPORT
Abstract—Osteomyelitis with severe skin and soft tissue dam-
age in critically ill patients cannot be treated solely by an
orthopaedic specialist. In such patients, a team approach is
required. We report the treatment of osteomyelitis in a HCV
and HIV positive patient with several severe comorbidities (liver
failure, peripheral vascular disease and peripheral neuropathy).
The patient underwent mechanical debridement, followed by
a three months of antibiotic therapy. Six months later the
infection relapsed and a second debridement was performed.
V.A.C.Ulta therapy with instillation of “Dermacyn” solution, a
super-oxidized disinfectant, as antiseptic solution was applied for
20 days and the wound healed. Three-years follow-up with inflam-
matory laboratory tests, clinical and radiographic examinations
showed healing of the wound without any relapse of infection. In
this paper, we suggest combining debridement and NPWT with
instillation for critical patients with severe soft tissue damage
that poorly respond to other therapies.
Keywords—antibiotic therapy, HCV, HIV, osteomyelitis, Nega-
tive Pressure Wound Therapy, instillation
I. INTRODUCTION
PSTEOMYELITIS is an heterogeneous disease encom-passing a spectrum of severity grades with different
therapeutic requirements that necessitate long-term follow-up.
Joint infections and osteomyelitis, especially involving foreign
implants, are difficult to treat and require prolonged antibiotic
therapy.1, 2 Therefore, the importance of antimicrobial therapy
in the treatment of osteomyelitis is unquestioned.3 Surgical
debridement is also a cornerstone in the treatment of patients
with osteomyelitis and removal of infected bone unquestion-
ably improves the chance of a successful outcome.
A male 44 year-old patient, born in Ukraine, HCV/HIV
coinfected with compromised immune response presented
relapse of knee infection with fistula, probably influenced by
the individual conditions of the host.4 Thus, the appropriate
therapeutic strategy in this case included aggressive surgical
debridement and vacuum assisted closure (VAC) therapy with
instillation of antiseptic solution.
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Figure 1. Initial wound debridement
II. CASE STUDY
In this paper, we report the case of a 44 year-old patient
affected by severe osteomyelitis and HCV/HIV infection. He
had a history of liver failure (HCV related hepatopathy) and
immunodeficiency. The patient had abused alcohol and illicit
drugs as well as heroine in the past but he denied using any
illicit drugs over the last six months.
On July 2nd 2012, during the first in-patient treatment,
the patient presented with severe sepsis and fever (>39◦C),
severe resting knee pain, local inflammation with sinus tract
and elevated laboratory values (CRP 80 mg/l; lymphocyte
count of 6000/ml). The wound exudate culture showed pos-
itive for methicilin resistant Staphylococcus aureus (MRSA).
The patient was HIV positive (HIV infection category A2
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Figure 2. Reinfection of the wound 6 months after initial therapy
according to the CDC classification5) with CD4 count equal
to 334 cells/µl and CD4/CD8 ratio of 0.64. CD4 cell count is
independent factor that affects wound healing in HIV/AIDS
patient. HIV 1-Quantitative RNA was 186,045 cp/ml and the
patient started receiving ATRIPLA (TDF+FTC+EFV) 1 tablet
daily on February 5th 2013.
An antibiotic regime tailored to the sensitivities of the
organism isolated from the obtained biopsy material was
started prior to surgical operation. Nevertheless, during the
operation a huge quantity of purulent material was discovered
and aspirated. Radical debridement was performed (Fig. I).
The patient was treated with a combination of 160 mg
sulfamethoxazole and 800 mg trimethoprim (TMP/SMZ) and
rifampicin (10 mg/kg body weight) orally for 3 months and
application of silver-coated dressings as bacterial barriers
(ACTICOAT, Smith & Nephew).
Six months later the infection relapsed with sinus tract
involvement and acute symptoms (Fig 2) and the patient was
reoperated and wound debridement was performed (Fig 3).
The skin was left open and V.A.C.Ulta Negative Pressure
Wound Therapy system was applied (pressure -125 mmHg)
with instillation of "Dermacyn" solution, a super-oxidized
disinfectant, as antiseptic solution. Dressing changes were
performed every two days. The V.A.C.Ulta was applied, for 20
days (Fig. 4). Skin closure was performed in two stages: first
the subcutaneous tissue and later on the skin. Three years later,
the patient had no signs of infection, rigid knee with limited
extension (< 170◦) and flexion (<40◦), limb shortening (< 3
cm), normal laboratory values, and was able to walk without
crutches or brace (Fig. 5).
III. DISCUSSION
Acute and chronic osteomyelitis, spondylodiscitis, and or-
thopedic implant infections are a heterogeneous group of in-
fectious disease entities. One common denominator is the com-
plex diagnostic and therapeutic challenges that are regularly
encountered by clinicians. The patient’s history, subjective
symptoms, and biochemical and physical findings are often
inconclusive, particularly in the early disease stages.
Figure 3. Second wound debridement
Figure 4. V.A.C.Ulta Therapy with instillation
After years in which planar scintigraphy used to be the stan-
dard in the diagnosis of osteomyelitis, the need for improved
localization was recently met by single-photon emission com-
puted tomography (SPECT) with 111In-WBC combined with
99m Tc-MDP or 99mTc-sulfur colloid and positron emis-
sion tomography with fludeoxyglucose (FDG/PET).6 However,
SPECT and FDG/PET are expensive for the health care system
and have showed low specificity for periprosthetic infection.
Osteomyelitis still presents problems in both diagnostic pro-
cedures and in treatment. When osteomyelitis is associated
with a foreign body or orthopedic device, it is common for
bacterial pathogens to persist despite antibiotic therapy, and
the infection is often cured only after removal of the implant
and debridement of necrotic bone.7 Radical debridement is
a prerequisite for cure in any orthopedic infection, as de-
bridement will remove the largest bio-burden, but even the
most careful cleaning cannot prevent residual small bacterial
colonies from forming new habitats in niches of the debrided
site. Surgical debridement is the cornerstone in the treatment
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of patients with osteomyelitis.8 All isolated pockets of granula-
tion tissue of necrosis must be sampled. Cleaning is finalized
using intense pulsatile lavage with saline combined with an
antiseptic solution to make sure to remove all necrotic tissue
in microscopic areas. An antibiotic susceptibility testing of the
organisms isolated from the obtained biopsy material should
be started after surgery.9 Multiple previous studies have noted
that diabetes, obesity, and liver failure predispose patients to a
number of complications, including wound infections, showing
that host compromised immune system may play a crucial role
in the outcome of the disease.10
Early and aggressive surgical treatment for these critical
patients is not sufficient to heal the infection and leads to poor
patient outcomes. Sometimes the infected foci are difficult to
eradicate and modified antibiotic therapy is necessary after
considering several factors, such as bacteremia, clinical find-
ings, serial debridement isolates and their sensitivities, inad-
equate serum bactericidal levels, abnormal laboratory studies,
and/or patient intolerances.11 Here, we describe the clinical
course of a critical patient with HCV/HIV coinfection and
immune deficiency who developed a severe knee infection. In
this patient scintigraphy was not performed. X-ray examina-
tion showed bone necrosis. The other diagnostic procedures
were not performed and were considered useless due to the
severe clinical picture with high fever, skin redness and acute
knee pain.
This critical patient was treated with multiple approaches, as
well as combinations of debridement and VAC therapy with in-
stillation of antiseptic solution that are not considered standard
care or current orthopedic practice. This patient presented with
acute illness, so difficult-to-heal wounds were successfully
treated with application of V.A.C.Ulta.4 The V.A.C.Ulta Ther-
apy System (KCI/Acelity USA) is an integrated wound therapy
system that provides Negative Pressure Therapy (NPT) with an
instillation option. V.A.C.Ulta Therapy consists of VAC ther-
apy coupled with automated, controlled delivery and removal
of topical wound solutions in the wound bed. This patient
HCV/HIV coinfected with compromised immune surveillance
showed acute illness, relapse of infection, and difficult wound
healing that was later on successfully treated by application of
V.A.C.Ulta. Three-years follow-up after care shows complete
healing of wounds, moderate knee pain, without any relapse
of infection and the patient walks under arm crutches at
home. Therefore, we suggest considering different therapeutic
strategies for patients with severe skin and soft tissue damage
and comorbidities. In our opinion, critical patients affected
by severe comorbidities could be treated using non-standard
procedures as well as negative pressure wound therapy with
instillation. However, it has to be considered that wounds
with osteomyelitis could be treated with NPWT after radical
debridement and initiation of appropriate antibiotic therapy. In
other case it is contraindicated.
The clinical conditions of the patient showed fairly satis-
factory outcomes at follow-up over 3 years. Accordingly, the
results of this study demonstrates the constant evolution of
surgical techniques, and that the combination of various ap-
proaches with non-standard procedures can give good clinical
outcomes, even though they are only applicable to a minority
Figure 5. Full weight-bearing leg wit a healed wound
of most severely ill patients.
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